Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

BUY
$9.86 - $23.83 $46,194 - $111,643
4,685 Added 46.97%
14,660 $147,000
Q1 2022

Apr 21, 2022

SELL
$29.67 - $60.28 $100,432 - $204,047
-3,385 Reduced 25.34%
9,975 $387,000
Q4 2021

Feb 01, 2022

BUY
$47.84 - $64.34 $245,658 - $330,385
5,135 Added 62.43%
13,360 $782,000
Q3 2021

Nov 15, 2021

SELL
$59.27 - $95.73 $770 - $1,244
-13 Reduced 0.16%
8,225 $487,000
Q2 2021

Jul 30, 2021

BUY
$67.25 - $92.52 $2,152 - $2,960
32 Added 0.39%
8,238 $715,000
Q1 2021

May 03, 2021

SELL
$72.16 - $117.4 $93,158 - $151,563
-1,291 Reduced 13.59%
8,206 $677,000
Q4 2020

Jan 28, 2021

BUY
$38.09 - $100.95 $98,005 - $259,744
2,573 Added 37.16%
9,497 $864,000
Q2 2020

Jul 28, 2020

BUY
$20.21 - $35.23 $35,266 - $61,476
1,745 Added 33.69%
6,924 $238,000
Q1 2020

May 06, 2020

BUY
$17.28 - $31.88 $38,793 - $71,570
2,245 Added 76.52%
5,179 $115,000
Q1 2019

Apr 29, 2019

SELL
$13.15 - $18.71 $12,242 - $17,419
-931 Reduced 24.09%
2,934 $52,000
Q4 2018

Jan 25, 2019

BUY
$11.48 - $16.98 $16,806 - $24,858
1,464 Added 60.97%
3,865 $50,000
Q3 2018

Nov 09, 2018

BUY
$8.75 - $16.29 $21,008 - $39,112
2,401 New
2,401 $39,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $136M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.